Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Grail | 2025 | Post-IPO Equity | Undisclosed | Menlo Park |
| Trumid | 2021 | Private Equity | Undisclosed | New York |
| Metanovas Biotech | 2026 | Series A | Undisclosed | Mountain View |
| RoboticPlus.AI | 2026 | Series D | Undisclosed | Shanghai |
| HjMicro | 2026 | Series B | Undisclosed | Hangzhou |
| YMC Semiconductor | 2026 | Series A | $101.3M | Wuxi Shi |
| Kingwills New Materials | 2026 | Series C | Undisclosed | Shanghai |
| UniXell Biotechnology | 2026 | Series A | $7.2M | Pudong |
| Angitia Biopharmaceuticals | 2026 | Series D | $130.0M | Westlake Village |
| Third Arc Bio | 2026 | Series A | $52.0M | Boston |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 26 | Grail | Post-IPO Equity | Undisclosed | Menlo Park, United States |
| 27 | Trumid | Private Equity | Undisclosed | New York, United States |
| 28 | Metanovas Biotech | Series A | Undisclosed | Mountain View, United States |
| 29 | RoboticPlus.AI | Series D | Undisclosed | Shanghai, China |
| 30 | HjMicro | Series B | Undisclosed | Hangzhou, China |
| 31 | YMC Semiconductor | Series A | $101.3M | Wuxi Shi, China |
| 32 | Kingwills New Materials | Series C | Undisclosed | Shanghai, China |
| 33 | UniXell Biotechnology | Series A | $7.2M | Pudong, China |
| 34 | Angitia Biopharmaceuticals | Series D | $130.0M | Westlake Village, United States |
| 35 | Third Arc Bio | Series A | $52.0M | Boston, United States |
Grail is a healthcare company that develops pan-cancer screening tests designed to detect cancers at an early stage.
Trumid is a financial technology company and fixed income electronic trading platform.
Metanovas develops drugs, dietary supplements, functional foods, and cosmetics using AI technology.
RoboticPlus.AI is an robtics company that helps in architectural tech by providing intelligent robotic products for the construction sector.
HjMicro develops higher efficiency and easier deployment server processor (CPU) chips based on the ARM architecture.
YMC Semiconductor is a manufacturer of semiconductor device special equipment.
Kingwills New Materials develops, produce and sell flash-spun metamaterial Kunlun Hypak.
UniXell Biotechnology is a new-generation cell therapy drug developer, focuses on the development of a new generation of cell therapy drugs.
Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.
Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases.
Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
ThinkForce is a Shanghai-based artificial intelligence chip maker.
Dishi Medical is a company that manufactures Ophthalmic Medical Devices and other micro-assisted robots supported by biotechnology.
Cryofocus Biotech cryoablation device manufacturer.
Designing innovative technologies focused on accelerating global access to biotherapeutics.
DayOne develops and operates hyperscale digital infrastructure supporting cloud, AI, and edge computing workloads for enterprise platforms.
NeueHCT is a renowned intelligent driving technology firm.
MAXVAX aims to provide novel vaccine development and commercialization.
MiAlgae is a biotechnology company that produces microalgae-based marine omega-3 ingredients for use in animal nutrition.
Airwallex is a global payments and financial platform that provides business accounts, payment solutions, and spend management tools.
Nanovision Technology is a high-tech enterprise focused on high-speed and high-precision radiology.
CenoBots, short for Cenozoic Robotics, is a leading commercial cleaning robotics company.
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.
Leading provider of high-end RISC-V based CPUs and customized SoC designs
WIZ.AI provides conversational AI platforms and virtual agents that engage customers through voice and digital channels.
Hillhouse Investment has invested in 217 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Hillhouse Investment's top investment sectors include Biotechnology, Health Care, Manufacturing, Medical, Artificial Intelligence (AI). The firm invests across 42 different industry categories.
Among tracked funding rounds, DayOne received $2.0B in a Series C round. Hillhouse Investment's total known invested capital is $18.0B.
Hillhouse Investment's average investment size is $151.3M across its portfolio of 217 companies.
Recent Hillhouse Investment portfolio additions include Grail, Trumid, Metanovas Biotech, RoboticPlus.AI, HjMicro. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors